News

Ingrown Toenails This painful issue happens when the edges or corners ... an autoimmune condition that affects people with psoriasis. It causes redness, swelling, and pain in the affected toes or ...
Johnson & Johnson (JNJ) posts promising late-stage trial data for plaque psoriasis icotrokinra developed with Protagonist ...
The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics may also be considered.
Biologic treatment costs for plaque psoriasis more than doubled from 2007 to 2021, despite cheaper alternatives. Switching to the lowest-cost biologic in each class could reduce treatment costs by ...
The results of an open-label extension study confirmed the interchangeability of biosimilar CT-917 with reference adalimumab for plaque psoriasis.
Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.
Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch ...
Psoriasis can feel all-consuming, but the right strategies and support can make life more manageable when you're going ...
Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...
This can be the case for those living with moderate to severe plaque psoriasis, an immune condition that causes dry, itchy and scaly patches (or plaques) to form across the skin 1 and that affects ...
The phase 3 ICONIC-TOTAL trial has been evaluating the drug in adults and adolescents aged 12 years and older with at least moderate plaque psoriasis affecting high-impact skin sites. It is estimated ...